You are here

P&T® Journal contents for January 2002


In this study, focus groups were conducted with pharmacy benefit decision-makers, to better understand the role of health-related quality-of-life information in the formulary management process.
Thomas Delate, MS, Frank R. Ernst, PharmD, and Stephen Joel Coons, PhD
Continuing Education Credit
The review explains the health and economic benefits of using combination drugs.
Albert Wertheimer, PhD and Alan Morrison, PhD


Matthew Grissinger, RPh, discusses the confusion with concentrated insulin, problems caused by the national fentanyl shortage, and a succinylcholine vial mix-up
Matthew Grissinger, RPh
Editor-in-Chief David B. Nash explains the concept of “Graceful Degradation.”
David B. Nash, MD, MBA
Prescription Washington
Stephen Barlas
Drug Forecast
A new semisynthetic antimicrobial to treat respiratory tract infections.
Thomas File, MD
Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.